These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2647062)

  • 1. A bio-engineered rubella E1 antigen.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1989; 104(1-2):63-75. PubMed ID: 2647062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.
    Starkey WG; Newcombe J; Corbett KM; Liu KM; Sanders PG; Best JM
    J Clin Microbiol; 1995 Feb; 33(2):270-4. PubMed ID: 7714176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of a soluble rubella virus E1 envelope protein.
    Seto NO; Gillam S
    J Med Virol; 1994 Oct; 44(2):192-9. PubMed ID: 7852960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
    Hunt AR; Cropp CB; Chang GJ
    J Virol Methods; 2001 Sep; 97(1-2):133-49. PubMed ID: 11483224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of a recombinant rubella E1 antigen expressed in E. coli.
    Londesborough P; Terry G; Ho-Terry L
    Arch Virol; 1992; 122(3-4):391-7. PubMed ID: 1731700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.
    Seppänen H; Huhtala ML; Vaheri A; Summers MD; Oker-Blom C
    J Clin Microbiol; 1991 Sep; 29(9):1877-82. PubMed ID: 1774311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.
    Lindqvist C; Schmidt M; Heinola J; Jaatinen R; Osterblad M; Salmi A; Keränen S; Akerman K; Oker-Blom C
    J Clin Microbiol; 1994 Sep; 32(9):2192-6. PubMed ID: 7814545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
    Wen H; Wang Z
    Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coli.
    Kocken CH; Geerligs HJ; Bos CA; Ab G; Weijer WJ; Drijfhout JW; Welling GW; Welling-Wester S
    Arch Virol; 1988; 103(3-4):267-74. PubMed ID: 2850785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of recombinant rubella virus E1 protein and initial application for detecting of antibody].
    Yi Y; Guo MZ; Yu T; Xu WB; Yang JY; Chen SY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):382-4. PubMed ID: 19469182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
    Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
    Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG; Metelli R; Valensin PE
    Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the bovine viral diarrhoea virus Osloss p80 protein: its use as ELISA antigen for cattle serum antibody detection.
    Vanderheijden N; De Moerlooze L; Vandenbergh D; Chappuis G; Renard A; Lecomte C
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1427-31. PubMed ID: 8393083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
    Gene; 1986; 49(2):189-97. PubMed ID: 2436976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to individual proteins of rubella virus.
    Loo TW; MacDonald I; Clarke DM; Trudel M; Tingle A; Gilam S
    J Virol Methods; 1986 May; 13(2):149-59. PubMed ID: 3734013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.